BVS Q3 2020 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$581M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$86M+4.5% YoY

Gross Profit

$62M72.7% margin

Operating Income

$7M8.1% margin

Net Income

$8M9.8% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

+48.1%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$20M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$479M

Total Liabilities

$334M

Stockholders' Equity

$143M

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$82M	+4.5%
Gross Profit	$62M	$61M	+3.1%
Operating Income	$7M	$11M	-34.6%
Net Income	$8M	$4M	+103.5%